khkh personal page - To The Moon

khkh

No personal profile

2Follow

2Followers

0Topic

0Badge

2022-01-05

Tell me your opinion about this news...

Activision Blizzard: Growth At A Reasonable Price And An Opportunity To Buy The Dip

2022-01-04

👍

Is $3 Trillion Just the Beginning for Apple?

2022-01-03

👍

This Warren Buffett-Backed Chinese Automaker Sold More EVs Than Xpeng, Li Auto, Nio Combined In 2021

2022-01-02

👍

2 No-Brainer Stocks Down 27% to 35% to Buy for 2022

2021-12-29

[Surprised]

Blockchain Stocks Dropped in Morning Trading

2021-12-27

👍

3 Dividend Stocks to Buy If the Market Crashes in 2022

2021-12-26

Ok

Why It’s Not the Time to Buy the Dip on Upstart

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3572305591772809","uuid":"3572305591772809","gmtCreate":1609225147435,"gmtModify":1609225147435,"name":"khkh","pinyin":"khkh","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":2,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.07.07","exceedPercentage":"60.09%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9008331528,"gmtCreate":1641356265537,"gmtModify":1676533605534,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572305591772809","authorIdStr":"3572305591772809"},"themes":[],"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9008331528","repostId":"1135862850","repostType":4,"repost":{"id":"1135862850","kind":"news","pubTimestamp":1641353379,"share":"https://ttm.financial/m/news/1135862850?lang=&edition=fundamental","pubTime":"2022-01-05 11:29","market":"us","language":"en","title":"Activision Blizzard: Growth At A Reasonable Price And An Opportunity To Buy The Dip","url":"https://stock-news.laohu8.com/highlight/detail?id=1135862850","media":"Seeking Alpha","summary":"SummaryFor investors looking for exposure to the gaming industry at a reasonable valuation, Activisi","content":"<html><head></head><body><p><b>Summary</b></p><ul><li>For investors looking for exposure to the gaming industry at a reasonable valuation, Activision is a logical choice.</li><li>All three segments of Activision have operating margins over 40%.</li><li>Activision was in the news for the wrong reasons in 2021, causing a significant selloff in the second half of the year.</li><li>I detail some of the options investors have with options.</li><li>Activision has a rock-solid balance sheet and is set up for continued double-digit dividend growth moving forward.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e80630282637efff26567607345ed833\" tg-width=\"1536\" tg-height=\"864\" width=\"100%\" height=\"auto\"/><span>imaginima/E+ via Getty Images</span></p><p><b>Investment Thesis</b></p><p>One of the unique pieces of the video game industry is that it’s constantly evolving. Activision Blizzard (ATVI) is one of the dominant video game producers out there. However, the company hasn’t released a new game since 2016 with Overwatch and instead relies on proven cash cows like Call of Duty and Candy Crush. Activision has three segments that have operating margins over 40%, which is impressive for any company. Activision has a rock solid balance sheet with huge amounts of cash, so I expect continued double digit dividend growth.</p><p>There are some drawbacks to consider as well. Despite the huge margins, video game is an industry where there isn’t a huge moat for established companies. Activision is also in the middle of legal turmoil over a sexual harassment and discrimination allegation, which is what led to a selloff in 2021. For investors that are bullish on Activision, there are some interesting choices available to those who are familiar with options. Personally, I will be waiting for a larger margin of safety before potentially pulling the trigger.</p><p><b>The Business</b></p><p>Activision consists of three divisions: Activision, Blizzard Entertainment, and King. The Activision segment includes Call of Duty, which has been a cash cow for the company for a long time. It also used to be one of my personal favorites in the past when I had more leisure time to burn on video games. The Blizzard segment includes Diablo, Overwatch, World of Warcraft, and Hearthstone, and other smaller console game franchises. The King segment is focused on mobile gaming, with popular games like Candy Crush.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1e7ce0542bb6801e8ef9772b2685ba59\" tg-width=\"640\" tg-height=\"163\" width=\"100%\" height=\"auto\"/><span>Source: Q3 Earnings</span></p><p>In a market environment where some companies are valued using pixie dust and metrics that make little sense, Activision stands out as a tech company with huge operating margins. Each segment has an operating margin at 40% or better, with the overall operating margin sitting at 41.6% for the whole company in the first nine months of 2021. I want to make it perfectly clear that these operating margins are absolutely massive for any industry. For investors who have confidence in the company’s continued ability to develop existing franchises and create compelling new releases, Activision is a proven operator in the video game industry that could be an interesting choice at current prices.</p><p>There are only a couple other companies that I can think of with operating margins over 40%. Microsoft (MSFT), Meta Platforms (FB), Visa (V), and Mastercard (MA) are a couple examples. These companies, like Activision, all represent mature companies at scale. Unlike Activision, these companies have significant moats based on their user base, industry, and product/service type.</p><p>In the video game industry, moats are practically nonexistent. The best games will win out, no matter the size of the producer. If Activision doesn’t stay on top of the development for existing franchises and potential new offerings, they will lose their dominant position. New competitors have an easier time entering an industry like video games than an industry like payment processing, social media, or operating systems and cloud computing.</p><p><b>Seasonal Variables</b></p><p>One of the things to note with Activision is that there are a couple of seasonal effects in play. The annual Call of Duty release typically occurs in early November, which usually leads to a surge in revenue for Activision. The segment makes up over 40% of the company’s revenues, so a surge in Call of Duty revenue in Q4 generally leads to increased revenues compared to the rest of the year.</p><p>Another thing to note is the Christmas holiday. Video games are some of the most popular gifts for kids, and the gift giving season is another thing that drives Q4 revenue to typically be higher for Activision. When you combine this with the poor share price performance in 2021 (-28%), Activision could be a timely buy the dip opportunity for investors looking for growth at a reasonable price. You can also see this pattern in the MAUs (monthly active users), which saw a bump in the quarter after Christmas, especially the Activision segment.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/db715a9f67f2c94dd480d3739368b98d\" tg-width=\"640\" tg-height=\"52\" width=\"100%\" height=\"auto\"/><span>Source: Q3 Earnings</span></p><p><b>Valuation</b></p><p>Activision represents a good growth at a reasonable price choice. Currently trading at 17.5x earnings, there is significant upside from current prices just based on valuation. Based on a return to a P/E = Growth rate formula, Activision could return 18% and trade above $90 per share by the end of 2023. If you are even more bullish and expect a return to the 25x normal multiple, shares could end up above $110 based on projections.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0cbac9e085ae299169181633529a6f2c\" tg-width=\"640\" tg-height=\"362\" width=\"100%\" height=\"auto\"/><span>Source: Fast Graphs</span></p><p>Activision represents an interesting pick for dividend growth investors and those looking for growth at a reasonable price. While the starting yield is low at 0.71%, I expect double digit dividend growth into the foreseeable future.</p><p>Activision also had $4B left on the buyback program at the end of Q3 and hasn’t repurchased any shares since the program was authorized. The authorization runs until February 2023. The buyback program represents well over 7% of the current $52B market cap. We will see if management took advantage of share price weakness in Q4 to start buying back stock when the company reports 2021 earnings in February. Part of the reason for the selloff in the second half of 2021 was due to a management scandal.</p><p><b>In the News for All of the Wrong Reasons</b></p><p>Activision has spent much of 2021 in the news for allegations of sexual harassment and discrimination.</p><blockquote>The company, known for hit video games such as Call of Duty and World of Warcraft, was sued by California’s Department of Fair Employment and Housing in July over allegations of sexual harassment, unequal pay and retaliation. The agency described a “frat boy culture” at the company and accused leadership of failing to take action.</blockquote><p>Employees have also signed a petition demanding that CEO Bobby Kotick resign. In my opinion, most of this will be settled eventually and blow over in due time, but news like this tends to drag on sentiment. So, while the business is performing well and the valuation is attractive, we might see some delay in that translating to stock performance.</p><p><b>Ways to Play It</b></p><p>Personally, I sold my shares of Activision earlier this year. The main reason for the sale was that I had stopped playing video games in 2020 (primarily Call of Duty) and I wasn’t able to follow the products that drive the business as closely as I had before. I also sold because the valuation seemed to be getting a little rich at the time and I wanted to add to another position.</p><p>I got a little lucky on the timing for sure, but the price has fallen to a place where I’m starting to get interested again. Shares are the simplest way for bulls to benefit, but investors with some familiarity with options might have some appealing ways to go long Activision.</p><p>Below are the options chains for Activision for 2023. The strike prices I would probably look at more closely for investors that might be interested are $70, $75, and $80. I will be keeping an eye out for a dip in shares before buying any calls though, as even a small drop in share price can make the price of these options much more appealing. My first choice here would probably be the $70 strike.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1360be88106d84ccf57ea39952905e49\" tg-width=\"640\" tg-height=\"339\" width=\"100%\" height=\"auto\"/><span>Source: Charles Schwab (as of 12/31 close)</span></p><p>I don’t buy calls unless they are LEAPs and I think the 2024 options could be interesting, especially for investors who think shares are headed north of $100 in the next couple years. These contracts are a little more expensive, but the $75, $80, and $85 strike could be interesting, especially if shares drop in the next month or two before reporting year-end earnings for 2021.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6fe48535e991169b11ed8b259555c764\" tg-width=\"640\" tg-height=\"341\" width=\"100%\" height=\"auto\"/><span>Source: Charles Schwab (as of 12/31 close)</span></p><p>More conservative investors could look to sell put contracts to generate income. I would only recommend this strategy to investors that are also fine owning the shares at the chosen strike price if they do get assigned. I pulled the 2/11/2022 chain to show some of the options that are a little over one month.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e162af4d071e5cef64837bbc893b34fe\" tg-width=\"640\" tg-height=\"427\" width=\"100%\" height=\"auto\"/><span>Source: Charles Schwab (as of 12/31 close)</span></p><p>The beauty of this strategy is that investors that want to own the shares anyway can run it over and over until shares do get assigned. From there, you can hold the shares or start selling calls to continue generating income. Investors that would like to be assigned the shares can pick a higher strike price for a higher premium, and investors that mainly want the options premium can choose a lower strike with lower risk of being assigned. In my opinion, each different options play only gets more attractive if the share price heads lower.</p><p><b>Conclusion</b></p><p>Activision is one of the giants in the video game industry. With three segments that all have huge operating margins, Activision is an attractive growth at a reasonable price pick. The company was in the news in 2021 for sexual harassment and discrimination allegations, which led to a selloff in the second half of the year.</p><p>I think that investors familiar with derivatives could have some interesting options available to them. I will be waiting for a potential dip before making any moves, but Activision at today&#39;s prices is a high margin business with a reasonable valuation and a long runway of double digit dividend growth. Throw in a rock solid balance sheet and a sizable buyback program for good measure and Activision could be headed for double digit returns over the next couple years.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Activision Blizzard: Growth At A Reasonable Price And An Opportunity To Buy The Dip</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nActivision Blizzard: Growth At A Reasonable Price And An Opportunity To Buy The Dip\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-05 11:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4477780-activision-growth-at-a-reasonable-price-and-an-opportunity-to-buy-the-dip><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryFor investors looking for exposure to the gaming industry at a reasonable valuation, Activision is a logical choice.All three segments of Activision have operating margins over 40%.Activision ...</p>\n\n<a href=\"https://seekingalpha.com/article/4477780-activision-growth-at-a-reasonable-price-and-an-opportunity-to-buy-the-dip\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ATVI":"动视暴雪"},"source_url":"https://seekingalpha.com/article/4477780-activision-growth-at-a-reasonable-price-and-an-opportunity-to-buy-the-dip","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135862850","content_text":"SummaryFor investors looking for exposure to the gaming industry at a reasonable valuation, Activision is a logical choice.All three segments of Activision have operating margins over 40%.Activision was in the news for the wrong reasons in 2021, causing a significant selloff in the second half of the year.I detail some of the options investors have with options.Activision has a rock-solid balance sheet and is set up for continued double-digit dividend growth moving forward.imaginima/E+ via Getty ImagesInvestment ThesisOne of the unique pieces of the video game industry is that it’s constantly evolving. Activision Blizzard (ATVI) is one of the dominant video game producers out there. However, the company hasn’t released a new game since 2016 with Overwatch and instead relies on proven cash cows like Call of Duty and Candy Crush. Activision has three segments that have operating margins over 40%, which is impressive for any company. Activision has a rock solid balance sheet with huge amounts of cash, so I expect continued double digit dividend growth.There are some drawbacks to consider as well. Despite the huge margins, video game is an industry where there isn’t a huge moat for established companies. Activision is also in the middle of legal turmoil over a sexual harassment and discrimination allegation, which is what led to a selloff in 2021. For investors that are bullish on Activision, there are some interesting choices available to those who are familiar with options. Personally, I will be waiting for a larger margin of safety before potentially pulling the trigger.The BusinessActivision consists of three divisions: Activision, Blizzard Entertainment, and King. The Activision segment includes Call of Duty, which has been a cash cow for the company for a long time. It also used to be one of my personal favorites in the past when I had more leisure time to burn on video games. The Blizzard segment includes Diablo, Overwatch, World of Warcraft, and Hearthstone, and other smaller console game franchises. The King segment is focused on mobile gaming, with popular games like Candy Crush.Source: Q3 EarningsIn a market environment where some companies are valued using pixie dust and metrics that make little sense, Activision stands out as a tech company with huge operating margins. Each segment has an operating margin at 40% or better, with the overall operating margin sitting at 41.6% for the whole company in the first nine months of 2021. I want to make it perfectly clear that these operating margins are absolutely massive for any industry. For investors who have confidence in the company’s continued ability to develop existing franchises and create compelling new releases, Activision is a proven operator in the video game industry that could be an interesting choice at current prices.There are only a couple other companies that I can think of with operating margins over 40%. Microsoft (MSFT), Meta Platforms (FB), Visa (V), and Mastercard (MA) are a couple examples. These companies, like Activision, all represent mature companies at scale. Unlike Activision, these companies have significant moats based on their user base, industry, and product/service type.In the video game industry, moats are practically nonexistent. The best games will win out, no matter the size of the producer. If Activision doesn’t stay on top of the development for existing franchises and potential new offerings, they will lose their dominant position. New competitors have an easier time entering an industry like video games than an industry like payment processing, social media, or operating systems and cloud computing.Seasonal VariablesOne of the things to note with Activision is that there are a couple of seasonal effects in play. The annual Call of Duty release typically occurs in early November, which usually leads to a surge in revenue for Activision. The segment makes up over 40% of the company’s revenues, so a surge in Call of Duty revenue in Q4 generally leads to increased revenues compared to the rest of the year.Another thing to note is the Christmas holiday. Video games are some of the most popular gifts for kids, and the gift giving season is another thing that drives Q4 revenue to typically be higher for Activision. When you combine this with the poor share price performance in 2021 (-28%), Activision could be a timely buy the dip opportunity for investors looking for growth at a reasonable price. You can also see this pattern in the MAUs (monthly active users), which saw a bump in the quarter after Christmas, especially the Activision segment.Source: Q3 EarningsValuationActivision represents a good growth at a reasonable price choice. Currently trading at 17.5x earnings, there is significant upside from current prices just based on valuation. Based on a return to a P/E = Growth rate formula, Activision could return 18% and trade above $90 per share by the end of 2023. If you are even more bullish and expect a return to the 25x normal multiple, shares could end up above $110 based on projections.Source: Fast GraphsActivision represents an interesting pick for dividend growth investors and those looking for growth at a reasonable price. While the starting yield is low at 0.71%, I expect double digit dividend growth into the foreseeable future.Activision also had $4B left on the buyback program at the end of Q3 and hasn’t repurchased any shares since the program was authorized. The authorization runs until February 2023. The buyback program represents well over 7% of the current $52B market cap. We will see if management took advantage of share price weakness in Q4 to start buying back stock when the company reports 2021 earnings in February. Part of the reason for the selloff in the second half of 2021 was due to a management scandal.In the News for All of the Wrong ReasonsActivision has spent much of 2021 in the news for allegations of sexual harassment and discrimination.The company, known for hit video games such as Call of Duty and World of Warcraft, was sued by California’s Department of Fair Employment and Housing in July over allegations of sexual harassment, unequal pay and retaliation. The agency described a “frat boy culture” at the company and accused leadership of failing to take action.Employees have also signed a petition demanding that CEO Bobby Kotick resign. In my opinion, most of this will be settled eventually and blow over in due time, but news like this tends to drag on sentiment. So, while the business is performing well and the valuation is attractive, we might see some delay in that translating to stock performance.Ways to Play ItPersonally, I sold my shares of Activision earlier this year. The main reason for the sale was that I had stopped playing video games in 2020 (primarily Call of Duty) and I wasn’t able to follow the products that drive the business as closely as I had before. I also sold because the valuation seemed to be getting a little rich at the time and I wanted to add to another position.I got a little lucky on the timing for sure, but the price has fallen to a place where I’m starting to get interested again. Shares are the simplest way for bulls to benefit, but investors with some familiarity with options might have some appealing ways to go long Activision.Below are the options chains for Activision for 2023. The strike prices I would probably look at more closely for investors that might be interested are $70, $75, and $80. I will be keeping an eye out for a dip in shares before buying any calls though, as even a small drop in share price can make the price of these options much more appealing. My first choice here would probably be the $70 strike.Source: Charles Schwab (as of 12/31 close)I don’t buy calls unless they are LEAPs and I think the 2024 options could be interesting, especially for investors who think shares are headed north of $100 in the next couple years. These contracts are a little more expensive, but the $75, $80, and $85 strike could be interesting, especially if shares drop in the next month or two before reporting year-end earnings for 2021.Source: Charles Schwab (as of 12/31 close)More conservative investors could look to sell put contracts to generate income. I would only recommend this strategy to investors that are also fine owning the shares at the chosen strike price if they do get assigned. I pulled the 2/11/2022 chain to show some of the options that are a little over one month.Source: Charles Schwab (as of 12/31 close)The beauty of this strategy is that investors that want to own the shares anyway can run it over and over until shares do get assigned. From there, you can hold the shares or start selling calls to continue generating income. Investors that would like to be assigned the shares can pick a higher strike price for a higher premium, and investors that mainly want the options premium can choose a lower strike with lower risk of being assigned. In my opinion, each different options play only gets more attractive if the share price heads lower.ConclusionActivision is one of the giants in the video game industry. With three segments that all have huge operating margins, Activision is an attractive growth at a reasonable price pick. The company was in the news in 2021 for sexual harassment and discrimination allegations, which led to a selloff in the second half of the year.I think that investors familiar with derivatives could have some interesting options available to them. I will be waiting for a potential dip before making any moves, but Activision at today's prices is a high margin business with a reasonable valuation and a long runway of double digit dividend growth. Throw in a rock solid balance sheet and a sizable buyback program for good measure and Activision could be headed for double digit returns over the next couple years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001588529,"gmtCreate":1641274341168,"gmtModify":1676533592139,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572305591772809","authorIdStr":"3572305591772809"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001588529","repostId":"1186421483","repostType":4,"repost":{"id":"1186421483","kind":"news","pubTimestamp":1641273099,"share":"https://ttm.financial/m/news/1186421483?lang=&edition=fundamental","pubTime":"2022-01-04 13:11","market":"us","language":"en","title":"Is $3 Trillion Just the Beginning for Apple?","url":"https://stock-news.laohu8.com/highlight/detail?id=1186421483","media":"Motley Fool","summary":"2022 started out on a winning note for the stock market overall -- and for the iPhone giant in particular.","content":"<html><head></head><body><p><b>Key Points</b></p><ul><li>Markets started 2022 on a high note.</li><li>Apple briefly topped the $3 trillion mark in market capitalization.</li><li>Further growth is quite possible.</li></ul><p>The stock market had great returns in 2021, and at least based on the first trading day of the year, 2022 looks like it&#39;s headed in the same direction. After getting off to a slow start in the morning hours, the <b>Dow Jones Industrial Average</b>(DJINDICES:^DJI),<b>S&amp;P 500</b>(SNPINDEX:^GSPC), and <b>Nasdaq Composite</b>&#39;s(NASDAQINDEX:^IXIC) all moved higher, with new all-time high closes for the Dow and S&amp;P.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bdfe23edfbd0597975a74a94f858eb48\" tg-width=\"1148\" tg-height=\"332\" width=\"100%\" height=\"auto\"/><span>DATA SOURCE: YAHOO! FINANCE.</span></p><p>Contributing to the rise in all three of these indexes was <b>Apple</b>(NASDAQ:AAPL), which finished the day up 2.5%. That left the iPhone maker just shy of a long-anticipated milestone. But for a brief part of the day, Apple&#39;s stock moved high enough to bring the company&#39;s market capitalization above the $3 trillion mark. As impressive as Apple&#39;s ascent has been, there&#39;s a good argument that the company might have a lot more growth left in the tank. Let&#39;s take a look at the reasons Apple investors should still be bullish after a monumental run higher -- and why the stock could pull all the major benchmarks higher with it.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d18f68ead9df69de80b3205fc356b94\" tg-width=\"2000\" tg-height=\"1036\" width=\"100%\" height=\"auto\"/><span>IMAGE SOURCE: APPLE.</span></p><p><b>A big milestone</b></p><p>Many investors had been calling for Apple&#39;s market cap to hit $3 trillion in 2022, and the stock didn&#39;t waste any time accommodating them. Apple&#39;s stock price has soared more than 360% in the past three years, and that doesn&#39;t even include the dividend income that shareholders have received along the way.</p><p>Part of Apple&#39;s appeal in recent years has been the fact that its stock often lacked the sky-high valuations that tech investors had to pay for newer, faster-growing companies. Even now, Apple trades at just over 8 times its trailing sales over the past 12 months, and at less than 32 times its trailing net income. That&#39;s a far cry from what in hindsight seems like ridiculous bargains from a few years ago, when price-to-earnings ratios were in the low teens and the stock traded at closer to 3 times sales.</p><p>From a business perspective, Apple has benefited immensely since early 2019. The rise of 5G wireless networks has led a disproportionately large number of iPhone users to move forward with plans to upgrade in order to take advantage of increased functionality. The pandemic boosted sales of Mac laptops and iPad tablets, and the company has seen a big ramp-up in the use of the services it offers its customers. All those factors have fed Apple&#39;s growth.</p><p>Moreover, many of those factors look poised to keep boosting the company&#39;s prospects. Admittedly, it&#39;s unclear whether the iPhone 13 will prove to be the peak of the 5G upgrade cycle, but shareholders can count on new innovations keeping interest in the smartphone high. Moreover, services and hardware will continue working hand in hand to drive the value of Apple&#39;s ecosystem higher.</p><p><b>A big boost to the indexes</b></p><p>One really interesting thing about Apple is that it has such a huge impact on the popular stock market indexes. Consider today&#39;s 2.5% move and what it meant:</p><ul><li>In the price-weighted Dow, Apple&#39;s $4.44 per share upward move was worth about 30 points, or roughly an eighth of today&#39;s gains.</li><li>In the Nasdaq 100, Apple has a weighting of about 11.6%, and it alone was responsible for about a quarter of the Nasdaq 100&#39;s 1.1% gain on the day.</li><li>In the S&amp;P 500, Apple&#39;s weight is about 6.9%. The stock accounted for slightly more than a quarter of the S&amp;P&#39;s percentage gain.</li></ul><p>Conversely, some have argued that Apple&#39;s gains have come at least somewhat from the rise in the popularity of index investing, especially with Nasdaq stocks. When index funds get new money, they use existing allocation percentages to buy new shares -- and that gives Apple stock a big fraction of every dollar that comes in.</p><p>Smart investors will want to keep an eye on Apple in 2022 and beyond. The company has shown the power of uniting a strong brand with booming consumer demand, and if the economy can continue to recover and grow, then a $4 trillion market cap for Apple might well come sooner than most expect.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is $3 Trillion Just the Beginning for Apple?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs $3 Trillion Just the Beginning for Apple?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-04 13:11 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/03/is-3-trillion-just-the-beginning-for-apple/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key PointsMarkets started 2022 on a high note.Apple briefly topped the $3 trillion mark in market capitalization.Further growth is quite possible.The stock market had great returns in 2021, and at ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/03/is-3-trillion-just-the-beginning-for-apple/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.fool.com/investing/2022/01/03/is-3-trillion-just-the-beginning-for-apple/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186421483","content_text":"Key PointsMarkets started 2022 on a high note.Apple briefly topped the $3 trillion mark in market capitalization.Further growth is quite possible.The stock market had great returns in 2021, and at least based on the first trading day of the year, 2022 looks like it's headed in the same direction. After getting off to a slow start in the morning hours, the Dow Jones Industrial Average(DJINDICES:^DJI),S&P 500(SNPINDEX:^GSPC), and Nasdaq Composite's(NASDAQINDEX:^IXIC) all moved higher, with new all-time high closes for the Dow and S&P.DATA SOURCE: YAHOO! FINANCE.Contributing to the rise in all three of these indexes was Apple(NASDAQ:AAPL), which finished the day up 2.5%. That left the iPhone maker just shy of a long-anticipated milestone. But for a brief part of the day, Apple's stock moved high enough to bring the company's market capitalization above the $3 trillion mark. As impressive as Apple's ascent has been, there's a good argument that the company might have a lot more growth left in the tank. Let's take a look at the reasons Apple investors should still be bullish after a monumental run higher -- and why the stock could pull all the major benchmarks higher with it.IMAGE SOURCE: APPLE.A big milestoneMany investors had been calling for Apple's market cap to hit $3 trillion in 2022, and the stock didn't waste any time accommodating them. Apple's stock price has soared more than 360% in the past three years, and that doesn't even include the dividend income that shareholders have received along the way.Part of Apple's appeal in recent years has been the fact that its stock often lacked the sky-high valuations that tech investors had to pay for newer, faster-growing companies. Even now, Apple trades at just over 8 times its trailing sales over the past 12 months, and at less than 32 times its trailing net income. That's a far cry from what in hindsight seems like ridiculous bargains from a few years ago, when price-to-earnings ratios were in the low teens and the stock traded at closer to 3 times sales.From a business perspective, Apple has benefited immensely since early 2019. The rise of 5G wireless networks has led a disproportionately large number of iPhone users to move forward with plans to upgrade in order to take advantage of increased functionality. The pandemic boosted sales of Mac laptops and iPad tablets, and the company has seen a big ramp-up in the use of the services it offers its customers. All those factors have fed Apple's growth.Moreover, many of those factors look poised to keep boosting the company's prospects. Admittedly, it's unclear whether the iPhone 13 will prove to be the peak of the 5G upgrade cycle, but shareholders can count on new innovations keeping interest in the smartphone high. Moreover, services and hardware will continue working hand in hand to drive the value of Apple's ecosystem higher.A big boost to the indexesOne really interesting thing about Apple is that it has such a huge impact on the popular stock market indexes. Consider today's 2.5% move and what it meant:In the price-weighted Dow, Apple's $4.44 per share upward move was worth about 30 points, or roughly an eighth of today's gains.In the Nasdaq 100, Apple has a weighting of about 11.6%, and it alone was responsible for about a quarter of the Nasdaq 100's 1.1% gain on the day.In the S&P 500, Apple's weight is about 6.9%. The stock accounted for slightly more than a quarter of the S&P's percentage gain.Conversely, some have argued that Apple's gains have come at least somewhat from the rise in the popularity of index investing, especially with Nasdaq stocks. When index funds get new money, they use existing allocation percentages to buy new shares -- and that gives Apple stock a big fraction of every dollar that comes in.Smart investors will want to keep an eye on Apple in 2022 and beyond. The company has shown the power of uniting a strong brand with booming consumer demand, and if the economy can continue to recover and grow, then a $4 trillion market cap for Apple might well come sooner than most expect.","news_type":1},"isVote":1,"tweetType":1,"viewCount":326,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001804209,"gmtCreate":1641207707239,"gmtModify":1676533582870,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572305591772809","authorIdStr":"3572305591772809"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001804209","repostId":"1146803297","repostType":4,"repost":{"id":"1146803297","kind":"news","pubTimestamp":1641204364,"share":"https://ttm.financial/m/news/1146803297?lang=&edition=fundamental","pubTime":"2022-01-03 18:06","market":"us","language":"en","title":"This Warren Buffett-Backed Chinese Automaker Sold More EVs Than Xpeng, Li Auto, Nio Combined In 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1146803297","media":"Benzinga","summary":"The Shenzhen-based, Chinese automaker BYD Co’s all-electric vehicle sales soared by more than double","content":"<html><head></head><body><p>The Shenzhen-based, Chinese automaker <b>BYD Co’s</b> all-electric vehicle sales soared by more than double in December, helping it outscore local rivals <b>Xpeng Inc</b>,<b>Nio Inc</b> and<b>Li Auto Inc</b> combined for the full year as well.</p><p><b>What Happened:</b>BYD, which is backed by <b>Warren Buffett-ledBerkshire Hathaway Inc</b>(NYSE:BRK-A) (NYSE:BRK-B), sold a record 48,317 battery-powered electric vehicles in December, a jump of 148% year-over-year and 4.7% over the previous month.</p><p>BYD sold 320,810 battery-powered electric vehicles last year, a jump of 144.9% over 2019.</p><p>For the full year, BYD sold more electric vehicles than Nio, Xpeng and Li combined. The three electric vehicle makers together delivered  280,075 electric vehicles in 2021.</p><p>BYD’s overall new energy vehicles sales jumped more than three-fold to 93,945 units in December from a year ago. BYD’s NEV portfolio consists of cars, buses, and trucks and includes hybrids as well.</p><p>Nio, Xpeng, and Li Auto are in a close contest. Xpeng delivered 16,000 electric vehicles in December, Li Auto delivered 14,087 Li ONEs and Nio squeezed out just a little over 10,000 units during the month.</p><p>German automaker <b>Volkswagen Group</b>, which started selling ID. electric vehicles in China in June, delivered 13, 787 IDs in the country last month.</p><p><b>Why It Matters:</b> China’s electric vehicle adoption is picking up pace as more players — spurred by increased demand — rush to roll out their products and charging services. Nearly all players in the segment including Nio, Xpeng, Li Auto, Volkswagen have a new product launch planned this year.</p><p>Tesla reported smashing global delivery numbers for December and 2021, a big chunk of which is expected to have come from China. <b>Elon Musk</b>-led Tesla doesn&#39;t give a geographical breakdown of the deliveries.</p><p><b>Price Action:</b> BYDDY shares closed 3.06% lower at $67.5 a share on Friday.</p><p></p></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Warren Buffett-Backed Chinese Automaker Sold More EVs Than Xpeng, Li Auto, Nio Combined In 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Warren Buffett-Backed Chinese Automaker Sold More EVs Than Xpeng, Li Auto, Nio Combined In 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 18:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/01/24857275/this-warren-buffett-backed-chinese-automaker-sold-more-evs-than-xpeng-li-auto-nio-combined-in-2021><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Shenzhen-based, Chinese automaker BYD Co’s all-electric vehicle sales soared by more than double in December, helping it outscore local rivals Xpeng Inc,Nio Inc andLi Auto Inc combined for the ...</p>\n\n<a href=\"https://www.benzinga.com/news/22/01/24857275/this-warren-buffett-backed-chinese-automaker-sold-more-evs-than-xpeng-li-auto-nio-combined-in-2021\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"01211":"比亚迪股份","002594":"比亚迪","BYDDY":"比亚迪ADR"},"source_url":"https://www.benzinga.com/news/22/01/24857275/this-warren-buffett-backed-chinese-automaker-sold-more-evs-than-xpeng-li-auto-nio-combined-in-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146803297","content_text":"The Shenzhen-based, Chinese automaker BYD Co’s all-electric vehicle sales soared by more than double in December, helping it outscore local rivals Xpeng Inc,Nio Inc andLi Auto Inc combined for the full year as well.What Happened:BYD, which is backed by Warren Buffett-ledBerkshire Hathaway Inc(NYSE:BRK-A) (NYSE:BRK-B), sold a record 48,317 battery-powered electric vehicles in December, a jump of 148% year-over-year and 4.7% over the previous month.BYD sold 320,810 battery-powered electric vehicles last year, a jump of 144.9% over 2019.For the full year, BYD sold more electric vehicles than Nio, Xpeng and Li combined. The three electric vehicle makers together delivered  280,075 electric vehicles in 2021.BYD’s overall new energy vehicles sales jumped more than three-fold to 93,945 units in December from a year ago. BYD’s NEV portfolio consists of cars, buses, and trucks and includes hybrids as well.Nio, Xpeng, and Li Auto are in a close contest. Xpeng delivered 16,000 electric vehicles in December, Li Auto delivered 14,087 Li ONEs and Nio squeezed out just a little over 10,000 units during the month.German automaker Volkswagen Group, which started selling ID. electric vehicles in China in June, delivered 13, 787 IDs in the country last month.Why It Matters: China’s electric vehicle adoption is picking up pace as more players — spurred by increased demand — rush to roll out their products and charging services. Nearly all players in the segment including Nio, Xpeng, Li Auto, Volkswagen have a new product launch planned this year.Tesla reported smashing global delivery numbers for December and 2021, a big chunk of which is expected to have come from China. Elon Musk-led Tesla doesn't give a geographical breakdown of the deliveries.Price Action: BYDDY shares closed 3.06% lower at $67.5 a share on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9003770981,"gmtCreate":1641092529619,"gmtModify":1676533571509,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572305591772809","authorIdStr":"3572305591772809"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003770981","repostId":"2200441314","repostType":4,"repost":{"id":"2200441314","kind":"highlight","pubTimestamp":1641085740,"share":"https://ttm.financial/m/news/2200441314?lang=&edition=fundamental","pubTime":"2022-01-02 09:09","market":"us","language":"en","title":"2 No-Brainer Stocks Down 27% to 35% to Buy for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2200441314","media":"Motley Fool","summary":"These hot tech stocks might be a steal at these prices.","content":"<html><head></head><body><p>While the stock market at large is hitting all-time highs, many technology stocks have been getting hammered in 2021. Despite this broad drop in tech companies, many businesses are seeing strong success operationally. The share prices are sinking, but these companies continue to grow their top-line and establish their leadership roles in their respective industries.</p><p>Both <b><a href=\"https://laohu8.com/S/PATH\">UiPath</a></b> (NYSE:PATH) and <b>Twilio</b> (NYSE:TWLO) are in this boat. Shares of both tech stocks have fallen 35% and nearly 30%, respectively, despite strong growth across their businesses. With large markets ahead of them, I think today&#39;s prices could be optimal buying opportunities to get these innovative stocks at a bargain.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8ba4359608f283fe2078db19e0b044a2\" tg-width=\"700\" tg-height=\"465\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>1. UiPath: Bringing AI to the enterprise</h2><p>We have all been doing something so tedious and repetitive at work that we wish we could simply have it magically completed. It is, after all, a huge waste of our time because we would rather work on more thought-intensive, engaging work. With artificial intelligence-powered virtual bots, UiPath is turning our wishes into commands.</p><p>The company offers automation software that can emulate a human by understanding what is on a screen, extracting data, and making critical decisions. However, this software can do it much faster than humans, making 58% fewer mistakes. UiPath uses robotic process automation (RPA) in tandem with humans to make businesses more efficient. With UiPath, real workers are not fired or eliminated but rather freed to work on more critical tasks. UiPath has saved some of its customers millions of hours and dollars, which is why over 9,600 customers use UiPath and are currently spending 44% more than they did <a href=\"https://laohu8.com/S/AONE.U\">one</a> year ago.</p><p>The stock has not fallen because of bad operational performance. The company has brought in $602.5 million in revenue so far this year, 50% higher than the year-ago period. Shares have taken a downturn because of the major uptick in the company&#39;s net loss. In the third quarter, the company lost almost $123 million -- more than the total net loss for the first nine months of 2020. This has been because UiPath has rapidly ramped up its spending on advertising, along with research and development.</p><p>This is not without good reason, however. The company projects that its addressable market will nearly double to $30 billion by 2024. UiPath is already the industry leader in RPA, according to <b>Gartner</b>&#39;s Magic Quadrant, but the company is ramping up spending to make sure its competitors like Automation Anywhere do not overtake them. With the RPA market growing so rapidly over the next few years, UiPath is spending now -- rather successfully -- to obtain brand recognition as the industry begins to explode.</p><p>Here&#39;s the bottom line: UiPath is the leader in a futuristic industry that is expected to grow rapidly over the next few years. With so much investment going toward capturing this growth, along with a dominant product that has caught the eyes of NASA and <b>Alphabet</b>, I think that today&#39;s share prices are a gift to long-term investors.</p><h2>2. Twilio: Falling victim to the tech sell-off</h2><p>With over 250,000 businesses using Twilio, most of us have used its technology without even recognizing it. Anyone who has ever communicated with a food delivery driver or <b>Lyft</b> driver has used Twilio&#39;s services unknowingly. The company is helping other enterprises communicate within apps, allowing consumers and businesses to connect easier. These services seem to have grown even more important for Twilio&#39;s users as they are now spending 31% more today than they did one year ago with the company.</p><p>Twilio posted year-over-year revenue growth of 65% in Q3, but some of that came from its acquisitions. Although the company has consistently been able to post impressive organic growth -- something most growth-by-acquisition companies lack. In Q3, the company&#39;s revenue improved 38% year over year organically, and it has been able to organically boost its top line by 34% or more year over year for the past nine quarters.</p><p>Shares have largely been sent downward in 2021, and Twilio&#39;s major net losses haven&#39;t been helping. The company lost $224 million in Q3, with almost $170 million of that being stock-based compensation. While this might be worrisome today, it is overshadowed by the impressive top-line growth that the company is seeing, both organically and inorganically, in this lucrative market. At 17 times sales, this stock is trading at levels not seen since mid-2020, leaving an opportunistic window for investors.</p><p>The use of in-app communication will only become more prevalent as the world continues to adopt these habits, and Twilio has been and will likely continue benefiting from it. Twilio&#39;s future is bright, which is why I think investors should consider taking advantage of these low stock prices today.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 No-Brainer Stocks Down 27% to 35% to Buy for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 No-Brainer Stocks Down 27% to 35% to Buy for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-02 09:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/01/01/2-no-brainer-stocks-down-27-to-35-to-buy-for-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>While the stock market at large is hitting all-time highs, many technology stocks have been getting hammered in 2021. Despite this broad drop in tech companies, many businesses are seeing strong ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/01/2-no-brainer-stocks-down-27-to-35-to-buy-for-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4505":"高瓴资本持仓","BK4097":"系统软件","BK4116":"互联网服务与基础架构","BK4528":"SaaS概念","BK4539":"次新股","TWLO":"Twilio Inc","BK4548":"巴美列捷福持仓","PATH":"UiPath","BK4561":"索罗斯持仓","BK4551":"寇图资本持仓"},"source_url":"https://www.fool.com/investing/2022/01/01/2-no-brainer-stocks-down-27-to-35-to-buy-for-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200441314","content_text":"While the stock market at large is hitting all-time highs, many technology stocks have been getting hammered in 2021. Despite this broad drop in tech companies, many businesses are seeing strong success operationally. The share prices are sinking, but these companies continue to grow their top-line and establish their leadership roles in their respective industries.Both UiPath (NYSE:PATH) and Twilio (NYSE:TWLO) are in this boat. Shares of both tech stocks have fallen 35% and nearly 30%, respectively, despite strong growth across their businesses. With large markets ahead of them, I think today's prices could be optimal buying opportunities to get these innovative stocks at a bargain.Image source: Getty Images.1. UiPath: Bringing AI to the enterpriseWe have all been doing something so tedious and repetitive at work that we wish we could simply have it magically completed. It is, after all, a huge waste of our time because we would rather work on more thought-intensive, engaging work. With artificial intelligence-powered virtual bots, UiPath is turning our wishes into commands.The company offers automation software that can emulate a human by understanding what is on a screen, extracting data, and making critical decisions. However, this software can do it much faster than humans, making 58% fewer mistakes. UiPath uses robotic process automation (RPA) in tandem with humans to make businesses more efficient. With UiPath, real workers are not fired or eliminated but rather freed to work on more critical tasks. UiPath has saved some of its customers millions of hours and dollars, which is why over 9,600 customers use UiPath and are currently spending 44% more than they did one year ago.The stock has not fallen because of bad operational performance. The company has brought in $602.5 million in revenue so far this year, 50% higher than the year-ago period. Shares have taken a downturn because of the major uptick in the company's net loss. In the third quarter, the company lost almost $123 million -- more than the total net loss for the first nine months of 2020. This has been because UiPath has rapidly ramped up its spending on advertising, along with research and development.This is not without good reason, however. The company projects that its addressable market will nearly double to $30 billion by 2024. UiPath is already the industry leader in RPA, according to Gartner's Magic Quadrant, but the company is ramping up spending to make sure its competitors like Automation Anywhere do not overtake them. With the RPA market growing so rapidly over the next few years, UiPath is spending now -- rather successfully -- to obtain brand recognition as the industry begins to explode.Here's the bottom line: UiPath is the leader in a futuristic industry that is expected to grow rapidly over the next few years. With so much investment going toward capturing this growth, along with a dominant product that has caught the eyes of NASA and Alphabet, I think that today's share prices are a gift to long-term investors.2. Twilio: Falling victim to the tech sell-offWith over 250,000 businesses using Twilio, most of us have used its technology without even recognizing it. Anyone who has ever communicated with a food delivery driver or Lyft driver has used Twilio's services unknowingly. The company is helping other enterprises communicate within apps, allowing consumers and businesses to connect easier. These services seem to have grown even more important for Twilio's users as they are now spending 31% more today than they did one year ago with the company.Twilio posted year-over-year revenue growth of 65% in Q3, but some of that came from its acquisitions. Although the company has consistently been able to post impressive organic growth -- something most growth-by-acquisition companies lack. In Q3, the company's revenue improved 38% year over year organically, and it has been able to organically boost its top line by 34% or more year over year for the past nine quarters.Shares have largely been sent downward in 2021, and Twilio's major net losses haven't been helping. The company lost $224 million in Q3, with almost $170 million of that being stock-based compensation. While this might be worrisome today, it is overshadowed by the impressive top-line growth that the company is seeing, both organically and inorganically, in this lucrative market. At 17 times sales, this stock is trading at levels not seen since mid-2020, leaving an opportunistic window for investors.The use of in-app communication will only become more prevalent as the world continues to adopt these habits, and Twilio has been and will likely continue benefiting from it. Twilio's future is bright, which is why I think investors should consider taking advantage of these low stock prices today.","news_type":1},"isVote":1,"tweetType":1,"viewCount":348,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009490597,"gmtCreate":1640747355147,"gmtModify":1676533538727,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572305591772809","authorIdStr":"3572305591772809"},"themes":[],"htmlText":"[Surprised]&nbsp;","listText":"[Surprised]&nbsp;","text":"[Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009490597","repostId":"1172682878","repostType":4,"repost":{"id":"1172682878","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640704390,"share":"https://ttm.financial/m/news/1172682878?lang=&edition=fundamental","pubTime":"2021-12-28 23:13","market":"us","language":"en","title":"Blockchain Stocks Dropped in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1172682878","media":"Tiger Newspress","summary":"Blockchain stocks dropped in morning trading.Marathon Digital, Bit Digital, Riot Blockchain, Coinbas","content":"<p>Blockchain stocks dropped in morning trading.Marathon Digital,&nbsp;Bit&nbsp;Digital,&nbsp;Riot Blockchain,&nbsp;Coinbase,&nbsp;Canaan,&nbsp;SOS Ltd&nbsp;and&nbsp;Ebang International&nbsp;fell&nbsp;between 3% and 8%.</p>\n<p><img src=\"https://static.tigerbbs.com/2d11548e5ec535c997a2f86f9c063122\" tg-width=\"416\" tg-height=\"417\" referrerpolicy=\"no-referrer\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Blockchain Stocks Dropped in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlockchain Stocks Dropped in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-28 23:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Blockchain stocks dropped in morning trading.Marathon Digital,&nbsp;Bit&nbsp;Digital,&nbsp;Riot Blockchain,&nbsp;Coinbase,&nbsp;Canaan,&nbsp;SOS Ltd&nbsp;and&nbsp;Ebang International&nbsp;fell&nbsp;between 3% and 8%.</p>\n<p><img src=\"https://static.tigerbbs.com/2d11548e5ec535c997a2f86f9c063122\" tg-width=\"416\" tg-height=\"417\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAN":"嘉楠科技","RIOT":"Riot Platforms","COIN":"Coinbase Global, Inc.","SOS":"SOS Limited","MARA":"MARA Holdings","EBON":"亿邦国际","BTBT":"Bit Digital, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172682878","content_text":"Blockchain stocks dropped in morning trading.Marathon Digital, Bit Digital, Riot Blockchain, Coinbase, Canaan, SOS Ltd and Ebang International fell between 3% and 8%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":449,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009143315,"gmtCreate":1640579524139,"gmtModify":1676533527251,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572305591772809","authorIdStr":"3572305591772809"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009143315","repostId":"2194717735","repostType":4,"repost":{"id":"2194717735","kind":"highlight","pubTimestamp":1640574360,"share":"https://ttm.financial/m/news/2194717735?lang=&edition=fundamental","pubTime":"2021-12-27 11:06","market":"us","language":"en","title":"3 Dividend Stocks to Buy If the Market Crashes in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2194717735","media":"Motley Fool","summary":"The next crash is always around the corner, so get ready.","content":"<p>Market crashes happen, and they tend to drag down the best stocks along with the rest of the market. It's impossible to predict the timing and severity of the next downturn, but it's easy to imagine <a href=\"https://laohu8.com/S/AONE.U\">one</a> occurring in the near term.</p>\n<p>The omicron variant keeps threatening to pinch the global economy. If the latest variant of concern quickly fizzles out, rising inflation could prompt the Federal Reserve to raise interest rates.</p>\n<p>These three companies make reliable dividend payments in good times and bad. Their stocks are up near 52-week highs at the moment, but an overall market downturn could push them down to highly attractive prices. Here's why you want to add them to your watchlist.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d784bb9fed5ec33b1ed889f22ffb6b4\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>1. Abbott Laboratories</h2>\n<p><b>Abbott Laboratories</b> (NYSE:ABT) shares have gained around 26% in 2021. At recent prices, the stock offers an anemic 1.4% dividend yield.</p>\n<p>Patient investors who've held shares of this Dividend Aristocrat have seen their quarterly payments rise 77% over the past five years. Despite the big payout bumps, Abbott only needed around 33% of the free cash flow its operations generated over the past year to make dividend payments. That means the company shouldn't have any trouble raising the payout in line with earnings growth in the foreseeable future.</p>\n<p>Abbott is a healthcare conglomerate that makes most of its money selling medical devices and diagnostics. Its medical-device segment is under some pressure due to COVID-19 because it takes a lot of doctor visits before patients can receive a new pacemaker or a replacement heart valve. Despite pandemic pressure, medical-device segment sales during the first nine months of 2021 rose 24.5% year over year to $10.6 billion.</p>\n<p>Diagnostics sales in the first nine months of 2021 soared a whopping 73% year over year to $11.2 billion. Soaring demand for COVID-19 tests isn't good news for the medical-device segment, but improved diagnostics sales more than make up the difference.</p>\n<p>It's been over 50 years since Abbott went a whole year without raising its dividend payout. Considering the company's well-diversified operation, investors can reasonably expect their payouts to keep rising for another decade or two.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/df00d3dd1509e35f75cdcc720ed18995\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>2. AbbVie</h2>\n<p>The second half of 2021 has been disastrous for most drugmaker stocks, but not <b>AbbVie</b> (NYSE:ABBV). Shares of the pharmaceutical giant are up more than 22% this year. Since spinning off from Abbott Laboratories in 2013, the stock has risen around 271%, but that's not the whole story. Once you factor in steadily rising dividend payments, investors who held on to their shares have already received a 438% total return since the beginning of 2013.</p>\n<p>Over the past eight years, AbbVie's dividend has risen a whopping 253%, and at recent prices, the stock offers a tempting 4.3% yield. Despite the rapid raises, the company needed just 42% of free cash flow generated over the past year to meet its rapidly rising dividend obligation.</p>\n<p>AbbVie has offered an above-average dividend since its inception because investors are rightfully nervous about the company's ability to keep raising it in the long run. This company's largest source of revenue, Humira, is also the world's top-selling drug, with sales that rose 5.6% year over year in the third quarter up to an annualized $21.7 billion.</p>\n<p>Humira lost market exclusivity in the EU in 2018, and now 85% of its sales come from the U.S. market. In about a year, biosimilar versions of Humira that are already approved by the Food and Drug Administration (FDA) are expected to finally begin hammering Humira sales into the dirt.</p>\n<p>A few years ago, Humira's demise would have been disastrous for AbbVie, but the company's done an outstanding job at using Humira cash flows to license, acquire, and develop new blockbuster drugs that will more than offset the losses. Third-quarter sales of Rinvoq, a once-daily pill for the treatment of rheumatoid arthritis that AbbVie launched in 2019,&nbsp;more than doubled year over year to an annualized $1.8 billion. Sales of Skyrizi, a psoriasis drug also launched in 2019, soared 83.3% year over year to an annualized $3.2 billion.</p>\n<p>The Botox brand of injectable botulinum toxin is far more resilient to the loss of exclusivity issues facing Humira because it isn't exactly exclusive in the first place. Cosmetic Botox is more popular than ever, with third-quarter sales that soared 39% year over year to an annualized $2.2 billion. Therapeutic Botox sales rose 23% year over year to an annualized $2.6 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a38a39e3008a5ed3fc1899ce26a04cb1\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>3. Johnson &amp; Johnson</h2>\n<p><b>Johnson &amp; Johnson</b> (NYSE:JNJ) shares haven't performed as well as Abbott's or AbbVie's this year. Slow-growing sales of consumer-health products like Q-tips and Band-Aids have finally pushed the company to spin off its consumer-health segment into a new company.</p>\n<p>You probably want to wait for the dips with Johnson &amp; Johnson because at recent prices, the stock offers an uninspiring 2.5% yield. Once the company splits in two, shareholders will receive two quarterly payouts that should add up to the same amount they were receiving before the spin-off, or even more.</p>\n<p>Johnson &amp; Johnson has raised its dividend every year for 60 straight years. Over the past five years, the payout has risen by 32.5%, which isn't amazing but more than enough to outpace inflation.</p>\n<p>While I'm not expecting a great deal of growth from the new consumer-health business, Johnson &amp; Johnson's pharmaceutical division is firing on all cylinders. While the company's COVID-19 vaccine gets the most attention, it's not a very important part of the company's overall pharmaceutical business.</p>\n<p>Johnson &amp; Johnson's total pharmaceutical sales in the third quarter rose 13.8% year over year. A new psoriasis drug called Tremfya and a cancer therapy called Darzalex provided most of the growth. With the company's new products leading the way, investors can look forward to a steadily growing dividend payout for many years to come.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dividend Stocks to Buy If the Market Crashes in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dividend Stocks to Buy If the Market Crashes in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 11:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/26/3-dividend-stocks-to-buy-if-market-crashes-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Market crashes happen, and they tend to drag down the best stocks along with the rest of the market. It's impossible to predict the timing and severity of the next downturn, but it's easy to imagine ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/26/3-dividend-stocks-to-buy-if-market-crashes-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","BK4550":"红杉资本持仓","BK4566":"资本集团","BK4504":"桥水持仓","JNJ":"强生","BK4532":"文艺复兴科技持仓","ABBV":"艾伯维公司","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4082":"医疗保健设备","BK4559":"巴菲特持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4568":"美国抗疫概念","ABT":"雅培"},"source_url":"https://www.fool.com/investing/2021/12/26/3-dividend-stocks-to-buy-if-market-crashes-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194717735","content_text":"Market crashes happen, and they tend to drag down the best stocks along with the rest of the market. It's impossible to predict the timing and severity of the next downturn, but it's easy to imagine one occurring in the near term.\nThe omicron variant keeps threatening to pinch the global economy. If the latest variant of concern quickly fizzles out, rising inflation could prompt the Federal Reserve to raise interest rates.\nThese three companies make reliable dividend payments in good times and bad. Their stocks are up near 52-week highs at the moment, but an overall market downturn could push them down to highly attractive prices. Here's why you want to add them to your watchlist.\nImage source: Getty Images.\n1. Abbott Laboratories\nAbbott Laboratories (NYSE:ABT) shares have gained around 26% in 2021. At recent prices, the stock offers an anemic 1.4% dividend yield.\nPatient investors who've held shares of this Dividend Aristocrat have seen their quarterly payments rise 77% over the past five years. Despite the big payout bumps, Abbott only needed around 33% of the free cash flow its operations generated over the past year to make dividend payments. That means the company shouldn't have any trouble raising the payout in line with earnings growth in the foreseeable future.\nAbbott is a healthcare conglomerate that makes most of its money selling medical devices and diagnostics. Its medical-device segment is under some pressure due to COVID-19 because it takes a lot of doctor visits before patients can receive a new pacemaker or a replacement heart valve. Despite pandemic pressure, medical-device segment sales during the first nine months of 2021 rose 24.5% year over year to $10.6 billion.\nDiagnostics sales in the first nine months of 2021 soared a whopping 73% year over year to $11.2 billion. Soaring demand for COVID-19 tests isn't good news for the medical-device segment, but improved diagnostics sales more than make up the difference.\nIt's been over 50 years since Abbott went a whole year without raising its dividend payout. Considering the company's well-diversified operation, investors can reasonably expect their payouts to keep rising for another decade or two.\nImage source: Getty Images.\n2. AbbVie\nThe second half of 2021 has been disastrous for most drugmaker stocks, but not AbbVie (NYSE:ABBV). Shares of the pharmaceutical giant are up more than 22% this year. Since spinning off from Abbott Laboratories in 2013, the stock has risen around 271%, but that's not the whole story. Once you factor in steadily rising dividend payments, investors who held on to their shares have already received a 438% total return since the beginning of 2013.\nOver the past eight years, AbbVie's dividend has risen a whopping 253%, and at recent prices, the stock offers a tempting 4.3% yield. Despite the rapid raises, the company needed just 42% of free cash flow generated over the past year to meet its rapidly rising dividend obligation.\nAbbVie has offered an above-average dividend since its inception because investors are rightfully nervous about the company's ability to keep raising it in the long run. This company's largest source of revenue, Humira, is also the world's top-selling drug, with sales that rose 5.6% year over year in the third quarter up to an annualized $21.7 billion.\nHumira lost market exclusivity in the EU in 2018, and now 85% of its sales come from the U.S. market. In about a year, biosimilar versions of Humira that are already approved by the Food and Drug Administration (FDA) are expected to finally begin hammering Humira sales into the dirt.\nA few years ago, Humira's demise would have been disastrous for AbbVie, but the company's done an outstanding job at using Humira cash flows to license, acquire, and develop new blockbuster drugs that will more than offset the losses. Third-quarter sales of Rinvoq, a once-daily pill for the treatment of rheumatoid arthritis that AbbVie launched in 2019, more than doubled year over year to an annualized $1.8 billion. Sales of Skyrizi, a psoriasis drug also launched in 2019, soared 83.3% year over year to an annualized $3.2 billion.\nThe Botox brand of injectable botulinum toxin is far more resilient to the loss of exclusivity issues facing Humira because it isn't exactly exclusive in the first place. Cosmetic Botox is more popular than ever, with third-quarter sales that soared 39% year over year to an annualized $2.2 billion. Therapeutic Botox sales rose 23% year over year to an annualized $2.6 billion.\nImage source: Getty Images.\n3. Johnson & Johnson\nJohnson & Johnson (NYSE:JNJ) shares haven't performed as well as Abbott's or AbbVie's this year. Slow-growing sales of consumer-health products like Q-tips and Band-Aids have finally pushed the company to spin off its consumer-health segment into a new company.\nYou probably want to wait for the dips with Johnson & Johnson because at recent prices, the stock offers an uninspiring 2.5% yield. Once the company splits in two, shareholders will receive two quarterly payouts that should add up to the same amount they were receiving before the spin-off, or even more.\nJohnson & Johnson has raised its dividend every year for 60 straight years. Over the past five years, the payout has risen by 32.5%, which isn't amazing but more than enough to outpace inflation.\nWhile I'm not expecting a great deal of growth from the new consumer-health business, Johnson & Johnson's pharmaceutical division is firing on all cylinders. While the company's COVID-19 vaccine gets the most attention, it's not a very important part of the company's overall pharmaceutical business.\nJohnson & Johnson's total pharmaceutical sales in the third quarter rose 13.8% year over year. A new psoriasis drug called Tremfya and a cancer therapy called Darzalex provided most of the growth. With the company's new products leading the way, investors can look forward to a steadily growing dividend payout for many years to come.","news_type":1},"isVote":1,"tweetType":1,"viewCount":540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009318863,"gmtCreate":1640491906203,"gmtModify":1676533523264,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3572305591772809","authorIdStr":"3572305591772809"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009318863","repostId":"1123414772","repostType":4,"repost":{"id":"1123414772","kind":"news","pubTimestamp":1640483546,"share":"https://ttm.financial/m/news/1123414772?lang=&edition=fundamental","pubTime":"2021-12-26 09:52","market":"us","language":"en","title":"Why It’s Not the Time to Buy the Dip on Upstart","url":"https://stock-news.laohu8.com/highlight/detail?id=1123414772","media":"InvestorPlace","summary":"Upstart (UPST)as a concept is extraordinary in my eyes because it assigns credit ratings with a much","content":"<p><b>Upstart (UPST)</b>as a concept is extraordinary in my eyes because it assigns credit ratings with a much more forward-looking approach than traditional loan facilitators do. Furthermore, the AI used by the firm is flawless, with speed and accuracy being the name of the game.</p>\n<p>However, as an investor, it’s critical to remind yourself that you’re investing in a stock and not only the company’s concept, which means that we need to determine whether its potential is priced-in or not.</p>\n<p>Next year’s market climate will be much different than it’s been the past 2-years. I, for one, expect a more price-efficient market, which means that investors will need to start distinguishing good companies from undervalued stock prices if they’re to realize gains.</p>\n<p>UPST stock could be a prime example of how a good company doesn’t always translate into a good stock.</p>\n<p>UPST stock Won’t Benefit From the Cyclical Trade</p>\n<p>Most of you would’ve heard about the rate hike buzz by now and how that will stimulate banking stocks. The theory behind this is that if the U.S. Federal Reserve raises interest rates, the debt market will be more lucrative to originators as the spreads they’d be able to charge on loans will increase.</p>\n<p>Upstart won’t necessarily benefit from this climate as it’s considered a hybrid between an advertising platform and a brokerage rather than a lender. This means that its revenue will actually decrease with higher rates because the transactional volume will likely taper off slightly as soon as rates rise.</p>\n<p>Further to the above, Upstart is a growth stock rather than a value play. Rising interest rates in 2022 could be detrimental to growth stocks as it tends to flatline their exponential earnings growth curve.</p>\n<p>Upstart’s revenue and EBITDA surged over the past year, coming in at187.56% and 447.28%respectively; these figures will likely diminish over the coming year, and I can’t help but think that the stock’s recent drawdown has been the market’s way of pricing in the expected decline in growth for next year.</p>\n<p>A final matter to mention regarding cyclicality isJ.P. Morgan’s recent neutral rating on the stock, with analyst James Faucette using a similar argument to mine in claiming that the stock’s growth has been priced in for now. Faucette thinks that Upstart’s relationship with its investors has enabled it to perform well in 2021, but the current market climate won’t allow that to sustain itself.</p>\n<p>Valuation &amp; Momentum</p>\n<p>Let’s start with the latter to provide context to the valuation argument. Upstart’s relative strength index (RSI) is below30, indicating that the stock has been oversold, but this doesn’t necessarily mean that it’s a “buy the dip opportunity.”</p>\n<p>For this to really be a buy low, sell high opportunity, we’d need to see an uptick in volume and a sign that the stock’s going to breach its moving averages; as of now UPST stock possesses neither of these attributes, and I believe that it’s due to a valuation issue.</p>\n<p>Here’s the big valuation problem; by comparing Upstart stock to its sector peers, it can be observed through price-sales and price-cash flow premiums of3.47x and 4.46xthat investors have gotten ahead of themselves. Adding to this is the argument that the stock could be the victim of a cyclical downturn, meaning that these ratios could play a key role in investor sell-offs moving forward.</p>\n<p>What now for UPST stock?</p>\n<p>A few investors are likely to buy into the recent dip, but I don’t think it will prevent a further downward trajectory. UPST stock has a massive valuation issue induced by over-optimism from investors during a pent-up broader market.</p>\n<p>Furthermore, the market’s set for a cyclical swing as monetary policy changes are en route, and Upstart stock’s characteristics mean that it could be a victim of such policies instead of being a beneficiary.</p>\n<p>The bottom line is that the stock isn’t worth the risk right now.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why It’s Not the Time to Buy the Dip on Upstart</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy It’s Not the Time to Buy the Dip on Upstart\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 09:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/upst-stock-upstart-why-its-not-the-time-to-buy-the-dip/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Upstart (UPST)as a concept is extraordinary in my eyes because it assigns credit ratings with a much more forward-looking approach than traditional loan facilitators do. Furthermore, the AI used by ...</p>\n\n<a href=\"https://investorplace.com/2021/12/upst-stock-upstart-why-its-not-the-time-to-buy-the-dip/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc."},"source_url":"https://investorplace.com/2021/12/upst-stock-upstart-why-its-not-the-time-to-buy-the-dip/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123414772","content_text":"Upstart (UPST)as a concept is extraordinary in my eyes because it assigns credit ratings with a much more forward-looking approach than traditional loan facilitators do. Furthermore, the AI used by the firm is flawless, with speed and accuracy being the name of the game.\nHowever, as an investor, it’s critical to remind yourself that you’re investing in a stock and not only the company’s concept, which means that we need to determine whether its potential is priced-in or not.\nNext year’s market climate will be much different than it’s been the past 2-years. I, for one, expect a more price-efficient market, which means that investors will need to start distinguishing good companies from undervalued stock prices if they’re to realize gains.\nUPST stock could be a prime example of how a good company doesn’t always translate into a good stock.\nUPST stock Won’t Benefit From the Cyclical Trade\nMost of you would’ve heard about the rate hike buzz by now and how that will stimulate banking stocks. The theory behind this is that if the U.S. Federal Reserve raises interest rates, the debt market will be more lucrative to originators as the spreads they’d be able to charge on loans will increase.\nUpstart won’t necessarily benefit from this climate as it’s considered a hybrid between an advertising platform and a brokerage rather than a lender. This means that its revenue will actually decrease with higher rates because the transactional volume will likely taper off slightly as soon as rates rise.\nFurther to the above, Upstart is a growth stock rather than a value play. Rising interest rates in 2022 could be detrimental to growth stocks as it tends to flatline their exponential earnings growth curve.\nUpstart’s revenue and EBITDA surged over the past year, coming in at187.56% and 447.28%respectively; these figures will likely diminish over the coming year, and I can’t help but think that the stock’s recent drawdown has been the market’s way of pricing in the expected decline in growth for next year.\nA final matter to mention regarding cyclicality isJ.P. Morgan’s recent neutral rating on the stock, with analyst James Faucette using a similar argument to mine in claiming that the stock’s growth has been priced in for now. Faucette thinks that Upstart’s relationship with its investors has enabled it to perform well in 2021, but the current market climate won’t allow that to sustain itself.\nValuation & Momentum\nLet’s start with the latter to provide context to the valuation argument. Upstart’s relative strength index (RSI) is below30, indicating that the stock has been oversold, but this doesn’t necessarily mean that it’s a “buy the dip opportunity.”\nFor this to really be a buy low, sell high opportunity, we’d need to see an uptick in volume and a sign that the stock’s going to breach its moving averages; as of now UPST stock possesses neither of these attributes, and I believe that it’s due to a valuation issue.\nHere’s the big valuation problem; by comparing Upstart stock to its sector peers, it can be observed through price-sales and price-cash flow premiums of3.47x and 4.46xthat investors have gotten ahead of themselves. Adding to this is the argument that the stock could be the victim of a cyclical downturn, meaning that these ratios could play a key role in investor sell-offs moving forward.\nWhat now for UPST stock?\nA few investors are likely to buy into the recent dip, but I don’t think it will prevent a further downward trajectory. UPST stock has a massive valuation issue induced by over-optimism from investors during a pent-up broader market.\nFurthermore, the market’s set for a cyclical swing as monetary policy changes are en route, and Upstart stock’s characteristics mean that it could be a victim of such policies instead of being a beneficiary.\nThe bottom line is that the stock isn’t worth the risk right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":668,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9003770981,"gmtCreate":1641092529619,"gmtModify":1676533571509,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572305591772809","idStr":"3572305591772809"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9003770981","repostId":"2200441314","repostType":4,"isVote":1,"tweetType":1,"viewCount":348,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001588529,"gmtCreate":1641274341168,"gmtModify":1676533592139,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572305591772809","idStr":"3572305591772809"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001588529","repostId":"1186421483","repostType":4,"isVote":1,"tweetType":1,"viewCount":326,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001804209,"gmtCreate":1641207707239,"gmtModify":1676533582870,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572305591772809","idStr":"3572305591772809"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001804209","repostId":"1146803297","repostType":4,"repost":{"id":"1146803297","kind":"news","pubTimestamp":1641204364,"share":"https://ttm.financial/m/news/1146803297?lang=&edition=fundamental","pubTime":"2022-01-03 18:06","market":"us","language":"en","title":"This Warren Buffett-Backed Chinese Automaker Sold More EVs Than Xpeng, Li Auto, Nio Combined In 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=1146803297","media":"Benzinga","summary":"The Shenzhen-based, Chinese automaker BYD Co’s all-electric vehicle sales soared by more than double","content":"<html><head></head><body><p>The Shenzhen-based, Chinese automaker <b>BYD Co’s</b> all-electric vehicle sales soared by more than double in December, helping it outscore local rivals <b>Xpeng Inc</b>,<b>Nio Inc</b> and<b>Li Auto Inc</b> combined for the full year as well.</p><p><b>What Happened:</b>BYD, which is backed by <b>Warren Buffett-ledBerkshire Hathaway Inc</b>(NYSE:BRK-A) (NYSE:BRK-B), sold a record 48,317 battery-powered electric vehicles in December, a jump of 148% year-over-year and 4.7% over the previous month.</p><p>BYD sold 320,810 battery-powered electric vehicles last year, a jump of 144.9% over 2019.</p><p>For the full year, BYD sold more electric vehicles than Nio, Xpeng and Li combined. The three electric vehicle makers together delivered  280,075 electric vehicles in 2021.</p><p>BYD’s overall new energy vehicles sales jumped more than three-fold to 93,945 units in December from a year ago. BYD’s NEV portfolio consists of cars, buses, and trucks and includes hybrids as well.</p><p>Nio, Xpeng, and Li Auto are in a close contest. Xpeng delivered 16,000 electric vehicles in December, Li Auto delivered 14,087 Li ONEs and Nio squeezed out just a little over 10,000 units during the month.</p><p>German automaker <b>Volkswagen Group</b>, which started selling ID. electric vehicles in China in June, delivered 13, 787 IDs in the country last month.</p><p><b>Why It Matters:</b> China’s electric vehicle adoption is picking up pace as more players — spurred by increased demand — rush to roll out their products and charging services. Nearly all players in the segment including Nio, Xpeng, Li Auto, Volkswagen have a new product launch planned this year.</p><p>Tesla reported smashing global delivery numbers for December and 2021, a big chunk of which is expected to have come from China. <b>Elon Musk</b>-led Tesla doesn&#39;t give a geographical breakdown of the deliveries.</p><p><b>Price Action:</b> BYDDY shares closed 3.06% lower at $67.5 a share on Friday.</p><p></p></body></html>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Warren Buffett-Backed Chinese Automaker Sold More EVs Than Xpeng, Li Auto, Nio Combined In 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Warren Buffett-Backed Chinese Automaker Sold More EVs Than Xpeng, Li Auto, Nio Combined In 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-03 18:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/01/24857275/this-warren-buffett-backed-chinese-automaker-sold-more-evs-than-xpeng-li-auto-nio-combined-in-2021><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Shenzhen-based, Chinese automaker BYD Co’s all-electric vehicle sales soared by more than double in December, helping it outscore local rivals Xpeng Inc,Nio Inc andLi Auto Inc combined for the ...</p>\n\n<a href=\"https://www.benzinga.com/news/22/01/24857275/this-warren-buffett-backed-chinese-automaker-sold-more-evs-than-xpeng-li-auto-nio-combined-in-2021\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"01211":"比亚迪股份","002594":"比亚迪","BYDDY":"比亚迪ADR"},"source_url":"https://www.benzinga.com/news/22/01/24857275/this-warren-buffett-backed-chinese-automaker-sold-more-evs-than-xpeng-li-auto-nio-combined-in-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146803297","content_text":"The Shenzhen-based, Chinese automaker BYD Co’s all-electric vehicle sales soared by more than double in December, helping it outscore local rivals Xpeng Inc,Nio Inc andLi Auto Inc combined for the full year as well.What Happened:BYD, which is backed by Warren Buffett-ledBerkshire Hathaway Inc(NYSE:BRK-A) (NYSE:BRK-B), sold a record 48,317 battery-powered electric vehicles in December, a jump of 148% year-over-year and 4.7% over the previous month.BYD sold 320,810 battery-powered electric vehicles last year, a jump of 144.9% over 2019.For the full year, BYD sold more electric vehicles than Nio, Xpeng and Li combined. The three electric vehicle makers together delivered  280,075 electric vehicles in 2021.BYD’s overall new energy vehicles sales jumped more than three-fold to 93,945 units in December from a year ago. BYD’s NEV portfolio consists of cars, buses, and trucks and includes hybrids as well.Nio, Xpeng, and Li Auto are in a close contest. Xpeng delivered 16,000 electric vehicles in December, Li Auto delivered 14,087 Li ONEs and Nio squeezed out just a little over 10,000 units during the month.German automaker Volkswagen Group, which started selling ID. electric vehicles in China in June, delivered 13, 787 IDs in the country last month.Why It Matters: China’s electric vehicle adoption is picking up pace as more players — spurred by increased demand — rush to roll out their products and charging services. Nearly all players in the segment including Nio, Xpeng, Li Auto, Volkswagen have a new product launch planned this year.Tesla reported smashing global delivery numbers for December and 2021, a big chunk of which is expected to have come from China. Elon Musk-led Tesla doesn't give a geographical breakdown of the deliveries.Price Action: BYDDY shares closed 3.06% lower at $67.5 a share on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009490597,"gmtCreate":1640747355147,"gmtModify":1676533538727,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572305591772809","idStr":"3572305591772809"},"themes":[],"htmlText":"[Surprised]&nbsp;","listText":"[Surprised]&nbsp;","text":"[Surprised]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009490597","repostId":"1172682878","repostType":4,"isVote":1,"tweetType":1,"viewCount":449,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009143315,"gmtCreate":1640579524139,"gmtModify":1676533527251,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572305591772809","idStr":"3572305591772809"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009143315","repostId":"2194717735","repostType":4,"repost":{"id":"2194717735","kind":"highlight","pubTimestamp":1640574360,"share":"https://ttm.financial/m/news/2194717735?lang=&edition=fundamental","pubTime":"2021-12-27 11:06","market":"us","language":"en","title":"3 Dividend Stocks to Buy If the Market Crashes in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2194717735","media":"Motley Fool","summary":"The next crash is always around the corner, so get ready.","content":"<p>Market crashes happen, and they tend to drag down the best stocks along with the rest of the market. It's impossible to predict the timing and severity of the next downturn, but it's easy to imagine <a href=\"https://laohu8.com/S/AONE.U\">one</a> occurring in the near term.</p>\n<p>The omicron variant keeps threatening to pinch the global economy. If the latest variant of concern quickly fizzles out, rising inflation could prompt the Federal Reserve to raise interest rates.</p>\n<p>These three companies make reliable dividend payments in good times and bad. Their stocks are up near 52-week highs at the moment, but an overall market downturn could push them down to highly attractive prices. Here's why you want to add them to your watchlist.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d784bb9fed5ec33b1ed889f22ffb6b4\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>1. Abbott Laboratories</h2>\n<p><b>Abbott Laboratories</b> (NYSE:ABT) shares have gained around 26% in 2021. At recent prices, the stock offers an anemic 1.4% dividend yield.</p>\n<p>Patient investors who've held shares of this Dividend Aristocrat have seen their quarterly payments rise 77% over the past five years. Despite the big payout bumps, Abbott only needed around 33% of the free cash flow its operations generated over the past year to make dividend payments. That means the company shouldn't have any trouble raising the payout in line with earnings growth in the foreseeable future.</p>\n<p>Abbott is a healthcare conglomerate that makes most of its money selling medical devices and diagnostics. Its medical-device segment is under some pressure due to COVID-19 because it takes a lot of doctor visits before patients can receive a new pacemaker or a replacement heart valve. Despite pandemic pressure, medical-device segment sales during the first nine months of 2021 rose 24.5% year over year to $10.6 billion.</p>\n<p>Diagnostics sales in the first nine months of 2021 soared a whopping 73% year over year to $11.2 billion. Soaring demand for COVID-19 tests isn't good news for the medical-device segment, but improved diagnostics sales more than make up the difference.</p>\n<p>It's been over 50 years since Abbott went a whole year without raising its dividend payout. Considering the company's well-diversified operation, investors can reasonably expect their payouts to keep rising for another decade or two.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/df00d3dd1509e35f75cdcc720ed18995\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>2. AbbVie</h2>\n<p>The second half of 2021 has been disastrous for most drugmaker stocks, but not <b>AbbVie</b> (NYSE:ABBV). Shares of the pharmaceutical giant are up more than 22% this year. Since spinning off from Abbott Laboratories in 2013, the stock has risen around 271%, but that's not the whole story. Once you factor in steadily rising dividend payments, investors who held on to their shares have already received a 438% total return since the beginning of 2013.</p>\n<p>Over the past eight years, AbbVie's dividend has risen a whopping 253%, and at recent prices, the stock offers a tempting 4.3% yield. Despite the rapid raises, the company needed just 42% of free cash flow generated over the past year to meet its rapidly rising dividend obligation.</p>\n<p>AbbVie has offered an above-average dividend since its inception because investors are rightfully nervous about the company's ability to keep raising it in the long run. This company's largest source of revenue, Humira, is also the world's top-selling drug, with sales that rose 5.6% year over year in the third quarter up to an annualized $21.7 billion.</p>\n<p>Humira lost market exclusivity in the EU in 2018, and now 85% of its sales come from the U.S. market. In about a year, biosimilar versions of Humira that are already approved by the Food and Drug Administration (FDA) are expected to finally begin hammering Humira sales into the dirt.</p>\n<p>A few years ago, Humira's demise would have been disastrous for AbbVie, but the company's done an outstanding job at using Humira cash flows to license, acquire, and develop new blockbuster drugs that will more than offset the losses. Third-quarter sales of Rinvoq, a once-daily pill for the treatment of rheumatoid arthritis that AbbVie launched in 2019,&nbsp;more than doubled year over year to an annualized $1.8 billion. Sales of Skyrizi, a psoriasis drug also launched in 2019, soared 83.3% year over year to an annualized $3.2 billion.</p>\n<p>The Botox brand of injectable botulinum toxin is far more resilient to the loss of exclusivity issues facing Humira because it isn't exactly exclusive in the first place. Cosmetic Botox is more popular than ever, with third-quarter sales that soared 39% year over year to an annualized $2.2 billion. Therapeutic Botox sales rose 23% year over year to an annualized $2.6 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a38a39e3008a5ed3fc1899ce26a04cb1\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>3. Johnson &amp; Johnson</h2>\n<p><b>Johnson &amp; Johnson</b> (NYSE:JNJ) shares haven't performed as well as Abbott's or AbbVie's this year. Slow-growing sales of consumer-health products like Q-tips and Band-Aids have finally pushed the company to spin off its consumer-health segment into a new company.</p>\n<p>You probably want to wait for the dips with Johnson &amp; Johnson because at recent prices, the stock offers an uninspiring 2.5% yield. Once the company splits in two, shareholders will receive two quarterly payouts that should add up to the same amount they were receiving before the spin-off, or even more.</p>\n<p>Johnson &amp; Johnson has raised its dividend every year for 60 straight years. Over the past five years, the payout has risen by 32.5%, which isn't amazing but more than enough to outpace inflation.</p>\n<p>While I'm not expecting a great deal of growth from the new consumer-health business, Johnson &amp; Johnson's pharmaceutical division is firing on all cylinders. While the company's COVID-19 vaccine gets the most attention, it's not a very important part of the company's overall pharmaceutical business.</p>\n<p>Johnson &amp; Johnson's total pharmaceutical sales in the third quarter rose 13.8% year over year. A new psoriasis drug called Tremfya and a cancer therapy called Darzalex provided most of the growth. With the company's new products leading the way, investors can look forward to a steadily growing dividend payout for many years to come.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dividend Stocks to Buy If the Market Crashes in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dividend Stocks to Buy If the Market Crashes in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 11:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/26/3-dividend-stocks-to-buy-if-market-crashes-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Market crashes happen, and they tend to drag down the best stocks along with the rest of the market. It's impossible to predict the timing and severity of the next downturn, but it's easy to imagine ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/26/3-dividend-stocks-to-buy-if-market-crashes-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","BK4550":"红杉资本持仓","BK4566":"资本集团","BK4504":"桥水持仓","JNJ":"强生","BK4532":"文艺复兴科技持仓","ABBV":"艾伯维公司","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4082":"医疗保健设备","BK4559":"巴菲特持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4568":"美国抗疫概念","ABT":"雅培"},"source_url":"https://www.fool.com/investing/2021/12/26/3-dividend-stocks-to-buy-if-market-crashes-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194717735","content_text":"Market crashes happen, and they tend to drag down the best stocks along with the rest of the market. It's impossible to predict the timing and severity of the next downturn, but it's easy to imagine one occurring in the near term.\nThe omicron variant keeps threatening to pinch the global economy. If the latest variant of concern quickly fizzles out, rising inflation could prompt the Federal Reserve to raise interest rates.\nThese three companies make reliable dividend payments in good times and bad. Their stocks are up near 52-week highs at the moment, but an overall market downturn could push them down to highly attractive prices. Here's why you want to add them to your watchlist.\nImage source: Getty Images.\n1. Abbott Laboratories\nAbbott Laboratories (NYSE:ABT) shares have gained around 26% in 2021. At recent prices, the stock offers an anemic 1.4% dividend yield.\nPatient investors who've held shares of this Dividend Aristocrat have seen their quarterly payments rise 77% over the past five years. Despite the big payout bumps, Abbott only needed around 33% of the free cash flow its operations generated over the past year to make dividend payments. That means the company shouldn't have any trouble raising the payout in line with earnings growth in the foreseeable future.\nAbbott is a healthcare conglomerate that makes most of its money selling medical devices and diagnostics. Its medical-device segment is under some pressure due to COVID-19 because it takes a lot of doctor visits before patients can receive a new pacemaker or a replacement heart valve. Despite pandemic pressure, medical-device segment sales during the first nine months of 2021 rose 24.5% year over year to $10.6 billion.\nDiagnostics sales in the first nine months of 2021 soared a whopping 73% year over year to $11.2 billion. Soaring demand for COVID-19 tests isn't good news for the medical-device segment, but improved diagnostics sales more than make up the difference.\nIt's been over 50 years since Abbott went a whole year without raising its dividend payout. Considering the company's well-diversified operation, investors can reasonably expect their payouts to keep rising for another decade or two.\nImage source: Getty Images.\n2. AbbVie\nThe second half of 2021 has been disastrous for most drugmaker stocks, but not AbbVie (NYSE:ABBV). Shares of the pharmaceutical giant are up more than 22% this year. Since spinning off from Abbott Laboratories in 2013, the stock has risen around 271%, but that's not the whole story. Once you factor in steadily rising dividend payments, investors who held on to their shares have already received a 438% total return since the beginning of 2013.\nOver the past eight years, AbbVie's dividend has risen a whopping 253%, and at recent prices, the stock offers a tempting 4.3% yield. Despite the rapid raises, the company needed just 42% of free cash flow generated over the past year to meet its rapidly rising dividend obligation.\nAbbVie has offered an above-average dividend since its inception because investors are rightfully nervous about the company's ability to keep raising it in the long run. This company's largest source of revenue, Humira, is also the world's top-selling drug, with sales that rose 5.6% year over year in the third quarter up to an annualized $21.7 billion.\nHumira lost market exclusivity in the EU in 2018, and now 85% of its sales come from the U.S. market. In about a year, biosimilar versions of Humira that are already approved by the Food and Drug Administration (FDA) are expected to finally begin hammering Humira sales into the dirt.\nA few years ago, Humira's demise would have been disastrous for AbbVie, but the company's done an outstanding job at using Humira cash flows to license, acquire, and develop new blockbuster drugs that will more than offset the losses. Third-quarter sales of Rinvoq, a once-daily pill for the treatment of rheumatoid arthritis that AbbVie launched in 2019, more than doubled year over year to an annualized $1.8 billion. Sales of Skyrizi, a psoriasis drug also launched in 2019, soared 83.3% year over year to an annualized $3.2 billion.\nThe Botox brand of injectable botulinum toxin is far more resilient to the loss of exclusivity issues facing Humira because it isn't exactly exclusive in the first place. Cosmetic Botox is more popular than ever, with third-quarter sales that soared 39% year over year to an annualized $2.2 billion. Therapeutic Botox sales rose 23% year over year to an annualized $2.6 billion.\nImage source: Getty Images.\n3. Johnson & Johnson\nJohnson & Johnson (NYSE:JNJ) shares haven't performed as well as Abbott's or AbbVie's this year. Slow-growing sales of consumer-health products like Q-tips and Band-Aids have finally pushed the company to spin off its consumer-health segment into a new company.\nYou probably want to wait for the dips with Johnson & Johnson because at recent prices, the stock offers an uninspiring 2.5% yield. Once the company splits in two, shareholders will receive two quarterly payouts that should add up to the same amount they were receiving before the spin-off, or even more.\nJohnson & Johnson has raised its dividend every year for 60 straight years. Over the past five years, the payout has risen by 32.5%, which isn't amazing but more than enough to outpace inflation.\nWhile I'm not expecting a great deal of growth from the new consumer-health business, Johnson & Johnson's pharmaceutical division is firing on all cylinders. While the company's COVID-19 vaccine gets the most attention, it's not a very important part of the company's overall pharmaceutical business.\nJohnson & Johnson's total pharmaceutical sales in the third quarter rose 13.8% year over year. A new psoriasis drug called Tremfya and a cancer therapy called Darzalex provided most of the growth. With the company's new products leading the way, investors can look forward to a steadily growing dividend payout for many years to come.","news_type":1},"isVote":1,"tweetType":1,"viewCount":540,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9008331528,"gmtCreate":1641356265537,"gmtModify":1676533605534,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572305591772809","idStr":"3572305591772809"},"themes":[],"htmlText":"Tell me your opinion about this news...","listText":"Tell me your opinion about this news...","text":"Tell me your opinion about this news...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9008331528","repostId":"1135862850","repostType":4,"isVote":1,"tweetType":1,"viewCount":360,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9009318863,"gmtCreate":1640491906203,"gmtModify":1676533523264,"author":{"id":"3572305591772809","authorId":"3572305591772809","name":"khkh","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3572305591772809","idStr":"3572305591772809"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9009318863","repostId":"1123414772","repostType":4,"repost":{"id":"1123414772","kind":"news","pubTimestamp":1640483546,"share":"https://ttm.financial/m/news/1123414772?lang=&edition=fundamental","pubTime":"2021-12-26 09:52","market":"us","language":"en","title":"Why It’s Not the Time to Buy the Dip on Upstart","url":"https://stock-news.laohu8.com/highlight/detail?id=1123414772","media":"InvestorPlace","summary":"Upstart (UPST)as a concept is extraordinary in my eyes because it assigns credit ratings with a much","content":"<p><b>Upstart (UPST)</b>as a concept is extraordinary in my eyes because it assigns credit ratings with a much more forward-looking approach than traditional loan facilitators do. Furthermore, the AI used by the firm is flawless, with speed and accuracy being the name of the game.</p>\n<p>However, as an investor, it’s critical to remind yourself that you’re investing in a stock and not only the company’s concept, which means that we need to determine whether its potential is priced-in or not.</p>\n<p>Next year’s market climate will be much different than it’s been the past 2-years. I, for one, expect a more price-efficient market, which means that investors will need to start distinguishing good companies from undervalued stock prices if they’re to realize gains.</p>\n<p>UPST stock could be a prime example of how a good company doesn’t always translate into a good stock.</p>\n<p>UPST stock Won’t Benefit From the Cyclical Trade</p>\n<p>Most of you would’ve heard about the rate hike buzz by now and how that will stimulate banking stocks. The theory behind this is that if the U.S. Federal Reserve raises interest rates, the debt market will be more lucrative to originators as the spreads they’d be able to charge on loans will increase.</p>\n<p>Upstart won’t necessarily benefit from this climate as it’s considered a hybrid between an advertising platform and a brokerage rather than a lender. This means that its revenue will actually decrease with higher rates because the transactional volume will likely taper off slightly as soon as rates rise.</p>\n<p>Further to the above, Upstart is a growth stock rather than a value play. Rising interest rates in 2022 could be detrimental to growth stocks as it tends to flatline their exponential earnings growth curve.</p>\n<p>Upstart’s revenue and EBITDA surged over the past year, coming in at187.56% and 447.28%respectively; these figures will likely diminish over the coming year, and I can’t help but think that the stock’s recent drawdown has been the market’s way of pricing in the expected decline in growth for next year.</p>\n<p>A final matter to mention regarding cyclicality isJ.P. Morgan’s recent neutral rating on the stock, with analyst James Faucette using a similar argument to mine in claiming that the stock’s growth has been priced in for now. Faucette thinks that Upstart’s relationship with its investors has enabled it to perform well in 2021, but the current market climate won’t allow that to sustain itself.</p>\n<p>Valuation &amp; Momentum</p>\n<p>Let’s start with the latter to provide context to the valuation argument. Upstart’s relative strength index (RSI) is below30, indicating that the stock has been oversold, but this doesn’t necessarily mean that it’s a “buy the dip opportunity.”</p>\n<p>For this to really be a buy low, sell high opportunity, we’d need to see an uptick in volume and a sign that the stock’s going to breach its moving averages; as of now UPST stock possesses neither of these attributes, and I believe that it’s due to a valuation issue.</p>\n<p>Here’s the big valuation problem; by comparing Upstart stock to its sector peers, it can be observed through price-sales and price-cash flow premiums of3.47x and 4.46xthat investors have gotten ahead of themselves. Adding to this is the argument that the stock could be the victim of a cyclical downturn, meaning that these ratios could play a key role in investor sell-offs moving forward.</p>\n<p>What now for UPST stock?</p>\n<p>A few investors are likely to buy into the recent dip, but I don’t think it will prevent a further downward trajectory. UPST stock has a massive valuation issue induced by over-optimism from investors during a pent-up broader market.</p>\n<p>Furthermore, the market’s set for a cyclical swing as monetary policy changes are en route, and Upstart stock’s characteristics mean that it could be a victim of such policies instead of being a beneficiary.</p>\n<p>The bottom line is that the stock isn’t worth the risk right now.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why It’s Not the Time to Buy the Dip on Upstart</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy It’s Not the Time to Buy the Dip on Upstart\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 09:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/upst-stock-upstart-why-its-not-the-time-to-buy-the-dip/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Upstart (UPST)as a concept is extraordinary in my eyes because it assigns credit ratings with a much more forward-looking approach than traditional loan facilitators do. Furthermore, the AI used by ...</p>\n\n<a href=\"https://investorplace.com/2021/12/upst-stock-upstart-why-its-not-the-time-to-buy-the-dip/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc."},"source_url":"https://investorplace.com/2021/12/upst-stock-upstart-why-its-not-the-time-to-buy-the-dip/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123414772","content_text":"Upstart (UPST)as a concept is extraordinary in my eyes because it assigns credit ratings with a much more forward-looking approach than traditional loan facilitators do. Furthermore, the AI used by the firm is flawless, with speed and accuracy being the name of the game.\nHowever, as an investor, it’s critical to remind yourself that you’re investing in a stock and not only the company’s concept, which means that we need to determine whether its potential is priced-in or not.\nNext year’s market climate will be much different than it’s been the past 2-years. I, for one, expect a more price-efficient market, which means that investors will need to start distinguishing good companies from undervalued stock prices if they’re to realize gains.\nUPST stock could be a prime example of how a good company doesn’t always translate into a good stock.\nUPST stock Won’t Benefit From the Cyclical Trade\nMost of you would’ve heard about the rate hike buzz by now and how that will stimulate banking stocks. The theory behind this is that if the U.S. Federal Reserve raises interest rates, the debt market will be more lucrative to originators as the spreads they’d be able to charge on loans will increase.\nUpstart won’t necessarily benefit from this climate as it’s considered a hybrid between an advertising platform and a brokerage rather than a lender. This means that its revenue will actually decrease with higher rates because the transactional volume will likely taper off slightly as soon as rates rise.\nFurther to the above, Upstart is a growth stock rather than a value play. Rising interest rates in 2022 could be detrimental to growth stocks as it tends to flatline their exponential earnings growth curve.\nUpstart’s revenue and EBITDA surged over the past year, coming in at187.56% and 447.28%respectively; these figures will likely diminish over the coming year, and I can’t help but think that the stock’s recent drawdown has been the market’s way of pricing in the expected decline in growth for next year.\nA final matter to mention regarding cyclicality isJ.P. Morgan’s recent neutral rating on the stock, with analyst James Faucette using a similar argument to mine in claiming that the stock’s growth has been priced in for now. Faucette thinks that Upstart’s relationship with its investors has enabled it to perform well in 2021, but the current market climate won’t allow that to sustain itself.\nValuation & Momentum\nLet’s start with the latter to provide context to the valuation argument. Upstart’s relative strength index (RSI) is below30, indicating that the stock has been oversold, but this doesn’t necessarily mean that it’s a “buy the dip opportunity.”\nFor this to really be a buy low, sell high opportunity, we’d need to see an uptick in volume and a sign that the stock’s going to breach its moving averages; as of now UPST stock possesses neither of these attributes, and I believe that it’s due to a valuation issue.\nHere’s the big valuation problem; by comparing Upstart stock to its sector peers, it can be observed through price-sales and price-cash flow premiums of3.47x and 4.46xthat investors have gotten ahead of themselves. Adding to this is the argument that the stock could be the victim of a cyclical downturn, meaning that these ratios could play a key role in investor sell-offs moving forward.\nWhat now for UPST stock?\nA few investors are likely to buy into the recent dip, but I don’t think it will prevent a further downward trajectory. UPST stock has a massive valuation issue induced by over-optimism from investors during a pent-up broader market.\nFurthermore, the market’s set for a cyclical swing as monetary policy changes are en route, and Upstart stock’s characteristics mean that it could be a victim of such policies instead of being a beneficiary.\nThe bottom line is that the stock isn’t worth the risk right now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":668,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}